drugset / Trial / NCT02710994
Pharmacodynamics and Safety of CDFR0209
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open-label, two-way crossover study to investigate the pharmacodynamics(24 hour gastric pH) and the safety between repeated doses of CDFR0209 and Losec in Healthy Male Volunteers
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 40 mg | — |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 1100 mg | — |